EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 60 / Numéro 1 (January-March 2025) Radioprotection, 60 1 (2025) 76-83 Références
Open Access
Numéro
Radioprotection
Volume 60, Numéro 1, January-March 2025
Page(s) 76 - 83
DOI https://doi.org/10.1051/radiopro/2024041
Publié en ligne 14 mars 2025
  • Aberle DR, Adams AM, et al. 2011. National lung screening trial research team. reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365: 395–409. [CrossRef] [PubMed] [Google Scholar]
  • Alberg AJ, Brock MV, Samet JM. 2005. Epidemiology of lung cancer: looking to the future. J Clin Oncol 23: 3175–3185. [CrossRef] [PubMed] [Google Scholar]
  • Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. 2007. Computed tomography screening and lung cancer outcomes. JAMA 297: 953–961. [CrossRef] [PubMed] [Google Scholar]
  • Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol. 2012 Sep;138(9):1475-86. doi: 10.1007/s00432-012-1228-9. [Google Scholar]
  • Bertho JM, Habib B. 2023. Radiation protection is an attitude. Radioprotection 58: 77–78. [CrossRef] [EDP Sciences] [Google Scholar]
  • Bianchi F, Nicassio F, Marzi M, Belloni E, Dall’olio V, Bernard L, et al. 2011. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Molec Med 3: 495–503. [CrossRef] [PubMed] [Google Scholar]
  • Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, et al. 2012. A multiplexed serum biomarkers immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol 7: 698–708. [CrossRef] [PubMed] [Google Scholar]
  • Bochicchio F, Campos-Venuti G, Piermattei S, Nuccetelli C, Risica S, Tommasino L, et al. 2005. Annual average and seasonal variations of residential radon concentration for all the Italian regions. Radiat Measur 40: 686–694. [CrossRef] [Google Scholar]
  • Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, et al. Dépiscan Group. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer. 2007 Oct;58(1):50-8. doi: 10.1016/j.lungcan.2007.05.009. [Google Scholar]
  • Bochicchio F, Forastiere F, Farchi S, Quarto M, Axelson O. 2005. Residential radon exposure, diet and lung cancer: a case-control study in a Mediterranean region. Int J Cancer 114: 983–991. [CrossRef] [PubMed] [Google Scholar]
  • Carrola J, et al. 2011. Metabolic signatures of lung cancer in biofluids, NMR-based metabonomics of urine. J Proteome Res 10: 221–230. [CrossRef] [PubMed] [Google Scholar]
  • Chapman CJ, et al. 2012. Early CDT-Lung test: improved clinical utility through additional autoantibody assays. Tumor Biol 33: 1319–1326. [CrossRef] [PubMed] [Google Scholar]
  • Chu GCW, Lazare K, Sullivan F. 2018. Serum and blood based biomarkers for lung cancer screening: a systematic review. BMC Cancer 18 (1): 181. [CrossRef] [PubMed] [Google Scholar]
  • Crispo A, Brennan P, Jockel KH, et al. 2004. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer 91: 1280–1286. [CrossRef] [PubMed] [Google Scholar]
  • Darby S, Hill D, Auvinen A, et al. 2005. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies BMJ 330 (7485): 223. [Google Scholar]
  • Directive 97/43/Euratom, based on ICRP pubblication 60, 1990 [Google Scholar]
  • Directive 2013 /59/Euratom. [Google Scholar]
  • European Commission, Directorate-General for Environment. Radiological protection principles concerning the natural radioactivity of building materials. Publications Office, Vol. 112, Radiation Protection 2000. [Google Scholar]
  • Epicentro ISS (Italian governmental Health Insitute). Radon − Epidemiological features- Available at: https://www.epicentro.iss.it/radon/epidemiologia#:∼:text=L’Iss%20ha%20stimato%20che,che%20ne%20moltiplica%20gli%20effetti [Google Scholar]
  • IARC. 2013. CancerBase No. 11. Lyon, International Agency for Research on Cancer. [Google Scholar]
  • Gasparri R et al. 2016. Volatile signature for early diagnosis of lung cancer. J Breath Res 10: 016007. [CrossRef] [PubMed] [Google Scholar]
  • Gasparri R, Romano R, Sedda G, Borri A, Petrella F, Galetta D, et al. 2017. Diagnostic biomarkers for lung cancer prevention. J. Breath Res 12(2028): 027111. [Google Scholar]
  • Gharibvand L, Shavlik D, Ghamsary M, et al. 2017. The Association between ambient fine particulate air pollution and lung cancer incidence: results from the AHSMOG-2 study. Environ Health Perspect 125 (3): 378–384. [CrossRef] [PubMed] [Google Scholar]
  • Haznadar M, et al. 2016. Urinary metabolite risk biomarkers of lung cancer: a prospective cohort study, Cancer Epidemiol Biomarkers Prev 25: 978–986. [CrossRef] [PubMed] [Google Scholar]
  • Henschke CI, McCauley DI, Yankelevitz DF, et al. 1999. Early lung cancer action project: overall design and findings from baseline screening. Lancet 354 (9173): 99–105. [CrossRef] [PubMed] [Google Scholar]
  • Henschke CI, Yankelevitz DF, et al. 2006. International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355 (17): 1763–1771. [CrossRef] [PubMed] [Google Scholar]
  • IARC. 1988. Man-Made Mineral Fibres and Radon. Lyon, France. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. IARC; 1988; Volume 43. [Google Scholar]
  • Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009 Sep 1;180(5):445-53. doi: 10.1164/rccm.200901-0076OC. [Google Scholar]
  • ICRP. 2007. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 37 (2–4). [Google Scholar]
  • ICRP. 2017. Occupational Intakes of Radionuclides: Part 3. ICRP Publication 137. Ann ICRP 46 (3/4). [Google Scholar]
  • Italian Law, Legislative Decree of 26 May 2000 no. 187. [Google Scholar]
  • Italian Law, Legislative Decree of 26 May 2000 no. 241 [Google Scholar]
  • Italian Law, Legislative Decree of 9 April 2008 no. 81, Articolo 17. [Google Scholar]
  • Italian Law, Legislative Decree of 31 July 2020 no. 101, Titolo II, Articolo 7, comma 40. [Google Scholar]
  • Italian Law, Legislative Decree of 31 July 2020 no. 101, Titolo II, Articolo 7, comma 40. [Google Scholar]
  • Italian Law Legislative Decree of 31 July 2020 no. 101, Titolo IV, Articolo 11. [Google Scholar]
  • Jett JR, Peek LJ, Fredericks L, Jewell W, Pingleton WW, JFR.R. 2014. Audit of the autoantibody test, EarlyCDT-lung, in 1600 patients: an evaluation of its performance in routine clinical practice. Lung Cancer (Amsterdam, Netherlands) 83 (1): 51–55. [CrossRef] [Google Scholar]
  • Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, et al. 2005. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology 16: 137–145. [CrossRef] [PubMed] [Google Scholar]
  • Lopes Pegna A, Picozzi G, Falaschi F, Carrozzi L, Falchini M, Carozzi FM, et al. ITALUNG Study Research Group. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol. 2013 Jul;8(7):866-75. doi: 10.1097/JTO.0b013e31828f68d6. [CrossRef] [Google Scholar]
  • Lorenzo-González M, Torres-Durán M, Barbosa-Lorenzo R, Provencio-Pulla M, Barros-Dios JM, Ruano-Ravina A. 2019. Radon exposure: a major cause of lung cancer. Expert Rev Respir Med 13 (9): 839–850. [CrossRef] [PubMed] [Google Scholar]
  • Montani F, Marzi MJ, Dezi F, Dama E, Carletti RM, Bonizzi G, et al. miR-Test: a blood test for lung cancer early detection. J Natl Cancer Inst 107 (6): djv063. [Google Scholar]
  • Park SL, Murphy SE, Wilkens LR, Stram DO, Hecht SS, Le Marchand L. 2017. Association of CYP2A6 activity with lung cancer incidence in smokers: the multiethnic cohort study. Plos ONE 12: e0178435. [CrossRef] [PubMed] [Google Scholar]
  • Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012 May;21(3):308-15. doi: 10.1097/CEJ.0b013e328351e1b6. [CrossRef] [PubMed] [Google Scholar]
  • Patz EF Jr, Pinsky P, Gatsonis C et al. 2014. Overdiagnosis in low-dose computed tomography screening for lungcancer. JAMA Intern Med 174 (2): 269–274. [CrossRef] [PubMed] [Google Scholar]
  • Peled N, Hakim M Jr, Bunn PA, Miller YE, Kennedy TC, Mattei J,et al. 2012. Non invasive breath analysis of pulmonary nodules. J Thorac Oncol 7: 1528–1533. [CrossRef] [PubMed] [Google Scholar]
  • Phillips M, et al. 2008. Detection of lung cancer using weighted difital analysis of breath biomarkers. Clin Chim Acta 393: 76–84. [CrossRef] [PubMed] [Google Scholar]
  • Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, et al. 1999. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 353: 1930–1933. [CrossRef] [PubMed] [Google Scholar]
  • Raaschou-Nielsen O, Andersen ZJ, Beelen R, et al. 2013. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol 14 (9): 813–822. [CrossRef] [PubMed] [Google Scholar]
  • Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012 Apr;67(4):296-301. doi: 10.1136/thoraxjnl-2011-200736. [CrossRef] [PubMed] [Google Scholar]
  • Sozzi G, Boeri M, Rossi M, et al. 2014. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol 32 (8): 768–773. [CrossRef] [PubMed] [Google Scholar]
  • Taylor R, Najafi F, Dobson A. 2007. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol 36: 1048–1059. [CrossRef] [PubMed] [Google Scholar]
  • UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). 2009. Effects of Ionising Radiation. UNSCEAR 2006 Report to the General Assembly − Volume II, Annex E: Sources-to-effects assessment for radon in homes and workplaces. New York: United Nations. [Google Scholar]
  • Uso M, Jantus-Lewintre E, Sirera R, Bremnes RM, Camps C. 2014. miRNA detection methods and clinical implications in lung cancer. Future Oncol 10 (14): 2279–2292. [CrossRef] [PubMed] [Google Scholar]
  • van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. de Koning HJ. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009 Dec 3;361(23):2221-9. doi: 10.1056/NEJMoa0906085. [CrossRef] [PubMed] [Google Scholar]
  • Wang C et al. 2015. A five-miRNA paneel identified from a multicentric case-control study serves as a novel diagnostic tool for ethnically diverse non small cell lung cancer patients. EBioMedicine 2: 1377–1385. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • World Health Organization. 2009. WHO Handbook on Indoor Radon: A Public Health Perspective. Geneva, Switzerland: World Health Organization. [Google Scholar]
  • Yokota J, Shiraishi K, Kohno T. 2010. Genetic basis for susceptibility to lung cancer: Recent progress and future directions. Adv Cancer Res 109: 51–72. [CrossRef] [PubMed] [Google Scholar]
  • Zhong L, Goldberg MS, Parent ME, Hanley JA. 2000. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer 27: 3–18. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.